Dr. David Fairchild, senior vice president and chief medical officer of retail health at CVS Health, tells this week’s Video Forum about the company’s ongoing efforts to combat smoking, vaping and nicotine use. Drawing on the findings of a recent national survey, he discusses the dangers of high levels of consumption of such products by teenagers and young adults, as well as smoking cessation programs and the need to counter misinformation in the marketplace.
Video Forum: Dr. David Fairchild, CVS Health
The battle against tobacco and nicotine use continues.
Related
Video Forum: Kenzie Hohman and Tim Weber, Cencora
Helping pharmacies innovate and improve their performance.
Video Forum: Jon Nordmark, Co-founder and CEO, Iterate.ai
AI’s impact on retail and CPG.
Video Forum: Meghan Galligan, Ahold Delhaize USA
Supermarket operator hones omnichannel marketing.
Latest
Independent Pharmacy Cooperative acquires USave Pharmacy Group
The deal brings together two organizations with a shared commitment to preserving and strengthening independent community pharmacy.
FDA approves Glenmark’s generic Flonase nasal spray
Fluticasone propionate is a corticosteroid used to treat nasal allergy symptoms, including congestion, sneezing, and a runny nose.
Rael gains TowerBrook backing for expansion
The investment will support Rael’s retail expansion, product innovation and global growth.
Yellow Wood Partners to acquire Nestlé's Holistic Health platform
$1.0 billion acquisition comprises VMS leading brands, including Nature's Bounty, the No. 2 VMS brand, and select specialty brands.